{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T04:29:25Z","timestamp":1690864165473},"reference-count":30,"publisher":"Georg Thieme Verlag KG","issue":"08","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Horm Metab Res"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of the study was to analyze the clinical suspicion and where patients\n                    were when they received the positive result of the neonatal screening for CAH\n                    21OHD. The present data derived from a retrospective analysis of a relatively\n                    large group of patients with classical CAH 21OHD patients nosed by newborn\n                    screening in Madrid, Spain. During the period from 1990 to 2015 of this study 46\n                    children were diagnosed with classical 21OHD [36 with the salt-wasting (SW) form\n                    and 10 with simple virilizing (SV)]. In 38 patients, the disease had not been\n                    suspected before the neonatal screening result (30 SW and 8 SV). Thirty patients\n                    (79%) were at home without suspicion of any disease, as healthy\n                    children, 3 patients (8%) were at home pending completion of the study\n                    due to clinical suspicion of any disease (ambiguous genitalia, cryptorchidism)\n                    and 5 patients (13%) were admitted to the hospital for reasons unrelated\n                    to CAH (sepsis, jaundice, hypoglycemia). It is relevant to note that\n                    69.4% of patients (25\/36) with SW form were at home with\n                    potential risk of adrenal crisis. Six females had been incorrectly labeled as\n                    male at birth. The most frequent reason for clinical suspicion was genital\n                    ambiguity in women followed by family history of the disease. Neonatal screening\n                    provided better results than clinical suspicion. In the majority of patients\n                    with 21OHD the diagnosis by screening was anticipated to the clinical suspicion\n                    of the disease even in female patients with ambiguous genitalia.<\/jats:p>","DOI":"10.1055\/a-2111-6571","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T23:21:00Z","timestamp":1686957660000},"page":"528-535","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the Degree of Clinical Suspicion of 21-Hydroxylase\n                    Deficiency Prior to the Newborn Screening Result"],"prefix":"10.1055","volume":"55","author":[{"given":"Mar\u00eda","family":"Sanz Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics & Pediatric Endocrinology, Hospital\n                    General Universitario Gregorio Mara\u00f1\u00f3n, Madrid,\n                    Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Mora Sitja","sequence":"additional","affiliation":[{"name":"Department of Pediatrics & Pediatric Endocrinology, Hospital\n                    General Universitario Gregorio Mara\u00f1\u00f3n, Madrid,\n                    Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Carrasc\u00f3n Gonz\u00e1lez-Pinto","sequence":"additional","affiliation":[{"name":"Department of Pediatrics & Pediatric Endocrinology, Hospital\n                    General Universitario Gregorio Mara\u00f1\u00f3n, Madrid,\n                    Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Est\u00edbaliz","family":"L\u00f3pez Herce Arteta","sequence":"additional","affiliation":[{"name":"Department of Pediatrics & Pediatric Endocrinology, Hospital\n                    General Universitario Gregorio Mara\u00f1\u00f3n, Madrid,\n                    Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Rodr\u00edguez S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics & Pediatric Endocrinology, Hospital\n                    General Universitario Gregorio Mara\u00f1\u00f3n, Madrid,\n                    Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"key":"ref1","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"P C White","year":"2000","journal-title":"Endocr Rev"},{"key":"ref2","first-page":"75","article-title":"The clinical and biochemical spectrum of congenital adrenal hyperplasia\n                    secundary to 21-hydroxylase deficiency","volume":"30","author":"T Huynh","year":"2009","journal-title":"Clin Biochem Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11154-007-9053-1","article-title":"Recent advances in diagnosis, treatment, and outcome of congenital adrenal\n                    hyperplasia due to 21-hydroxylase deficiency","volume":"8","author":"F G Riepe","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ecl.2009.08.001","article-title":"Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia","volume":"38","author":"S Nimkarn","year":"2009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/humupd\/dmh047","article-title":"Recent advances in the diagnosis and management of congenital adrenal\n                    hyperplasia due to 21-hydroxylase deficiency","volume":"10","author":"M G Forest","year":"2004","journal-title":"Hum Reprod Update"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","article-title":"Congenital adrenal hyperplasia","volume":"365","author":"D P Merke","year":"2005","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1210\/jc.2006-1645","article-title":"Extensive clinical esperience: nonclassical 21-hydroxylase deficiency","volume":"91","author":"M I New","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-45-5-1003","article-title":"Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its\n                    application for rapid screening for congenital adrenal hyperplasia","volume":"45","author":"S Pang","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1542\/peds.101.4.583","article-title":"Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient\n                    congenital adrenal hyperplasia","volume":"101","author":"BL BS Therrell","year":"1998","journal-title":"Pediatrics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrendo.2009.148","article-title":"Neonatal screening for congenital adrenal hyperplasia","volume":"5","author":"P C White","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"ref11","first-page":"155","article-title":"Neonatal screening for congenital adrenal hyperplasia: transitory elevation of\n                    17-hydroxyprogesterone","volume":"24","author":"B Huidobro Fern\u00e1ndez","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref12","first-page":"61","article-title":"Eguileor-Gurtubai. Programas de cribado neonatal","volume":"4","author":"EE M Dulin-Iniguez","year":"2006","journal-title":"An Pediatr Contin"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an\n                    endocrine society clinical practice guideline","volume":"95","author":"P W Speiser","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2002-020611","article-title":"Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins\n                    Pediatric Endocrine Society and the European Society for Paediatric\n                    Endocrinology","volume":"87","author":"PE MW Clayton","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","first-page":"284","article-title":"How many deaths can be prevented by newborn screening for congenital adrenal\n                    hyperplasia?","volume":"67","author":"S D Grosse","year":"2007","journal-title":"Horm Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1001\/archpedi.153.12.1272","article-title":"Effect of newborn screening for congenital adrenal hyperplasia","volume":"153","author":"P G Brosnan","year":"1999","journal-title":"Archiv Pediatr Adolesc Med"},{"key":"ref17","first-page":"2958","article-title":"Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal\n                    hyperplasia in five middle European countries","volume":"86","author":"J Kovacs","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","first-page":"691","article-title":"Neonatal screening for congenital adrenal hyperplasia in Taiwan: a pilot\n                    study","volume":"101","author":"SY TW Chu","year":"2002","journal-title":"J Formos Med Assoc"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1210\/jc.2002-012093","article-title":"High reliability of neonatal screening for congenital adrenal hyperplasia in\n                    Switzerland","volume":"87","author":"M Steigert","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","first-page":"271","article-title":"Neonatal screening program for congenital adrenal hyperplasia: adjustments to\n                    the recall protocol","volume":"55","author":"L PL Gruneiro-Papendieck","year":"2001","journal-title":"Horm Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1542\/peds.108.6.1320","article-title":"Newborn screening for congenital adrenal hyperplasia in the Netherlands","volume":"108","author":"HJ NK Van der Kamp","year":"2001","journal-title":"Pediatrics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0929-693X(99)80202-4","article-title":"Neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase\n                    deficiency: Lille experience 1980-1996","volume":"6","author":"M GN Cartigny-Maciejewski","year":"1999","journal-title":"Arch Pediatr"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1542\/peds.101.4.e11","article-title":"Benefits of neonatal screening for congenital adrenal hyperplasia\n                    (21-hydroxylase deficiency) in Sweden","volume":"101","author":"A NA Thil'en","year":"1998","journal-title":"Pediatrics"},{"key":"ref24","first-page":"362","article-title":"Congenital adrenal hyperplasia: neonatal mass screening compared with clinical\n                    diagnosis only in the Emilia-Romagna region of Italy, 1980-1995","volume":"98","author":"A CE Balsamo","year":"1996","journal-title":"Pediatrics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000185500","article-title":"21-Hydroxylase deficiency: screening and incidence in Israel","volume":"48","author":"J FH Sack","year":"1997","journal-title":"Horm Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-3476(97)70321-4","article-title":"Improved precision of newborn screening for congenital adrenal hyperplasia using\n                    weight-adjusted criteria for 17-hydroxyprogesterone levels","volume":"130","author":"DB HG Allen","year":"1997","journal-title":"J Pediatr"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00431-006-0154-8","article-title":"Prevalence of congenital adrenal hyperplasia among sudden infant death in the\n                    Czech Republic and Austria","volume":"166","author":"K A Strnadova","year":"2007","journal-title":"Eur J Pediatr"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-8587(13)70007-X","article-title":"One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective,\n                    population-based cohort study","volume":"1","author":"S FH Gidlof","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref30","first-page":"22","article-title":"Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency\n                    in England: implications for neonatal screening","volume":"63","author":"A Nordenstr\u00f6m","year":"2005","journal-title":"Horm Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jfma.2017.03.008","article-title":"Clinical characteristics of Taiwanese children with congenital adrenal\n                    hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening","volume":"117","author":"S Y Liu","year":"2018","journal-title":"J Formos Med Assoc"}],"container-title":["Hormone and Metabolic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2111-6571.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T22:32:00Z","timestamp":1690842720000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2111-6571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":30,"journal-issue":{"issue":"08","published-online":{"date-parts":[[2023,7,31]]},"published-print":{"date-parts":[[2023,8]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2111-6571","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0018-5043","1439-4286"],"issn-type":[{"value":"0018-5043","type":"print"},{"value":"1439-4286","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,16]]},"published":{"date-parts":[[2023,6,16]]}}}